Haemolytic uraemic syndrome due to ciprofloxacin-resistant Shigella dysenteriae serotype 1.
A case of haemolytic uraemic syndrome following dysentery due to ciprofloxacin-resistant Shigella dysenteriae serotype 1 is reported for the first time. The increasing resistance of S. dysenteriae serotype 1 to many commonly available antimicrobial agents has implications for the management of dysentery. The choice of antimicrobial treatment for S. dysenteriae serotype 1 infections should take into account widespread drug resistance and the risk of haemolytic uraemic syndrome.
Taneja
Neelam
N
Department of Medical Microbiology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh 160012, India.
Lyngdoh
Valarie W
VW
Department of Medical Microbiology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh 160012, India.
Sharma
Meera
M
Department of Medical Microbiology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh 160012, India.
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D002675:Child, Preschool; D002939:Ciprofloxacin / Q000494:pharmacology*; D024881:Drug Resistance, Bacterial; D004405:Dysentery, Bacillary / Q000150:complications* / Q000382:microbiology; D005260:Female; D006463:Hemolytic-Uremic Syndrome / Q000382:microbiology*; D006801:Humans; D012703:Serotyping; D012762:Shigella dysenteriae / Q000187:drug effects* / Q000302:isolation & purification*
D000900:Anti-Bacterial Agents; D002939:Ciprofloxacin